| Financial Year |
March 31 2023 |
| Monetary Funds |
439,855,995.27 |
| Held-for-trading Financial Assets |
13,539,829.94 |
| Notes Receivable |
14,632,500.00 |
| Accounts Receivable |
402,606,026.13 |
| Advances to Suppliers |
5,753,905.41 |
| Other Receivables |
15,337,656.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
31,987,377.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
202,471,209.06 |
| Other Current Assets |
8,623,865.40 |
| Total Current Assets |
1,638,782,146.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,297,801,929.36 |
| Long-term Equity Investment |
214,439,687.92 |
| Investment Properties |
17,314,720.42 |
| Fixed Assetes |
59,108,376.51 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
158,990.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,375,953.09 |
| Deferred Income Tax Assets |
15,475,196.91 |
| Other Non-Current Assets |
13,560,806.05 |
| Sub-Total of Non-Current Assets |
1,629,895,113.07 |
| Total Assets |
3,268,677,259.58 |
| Short-Term Loans |
229,280,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,737,381.16 |
| Accounts Payable |
316,528,287.83 |
| Accounts Received In Advance |
23,224.93 |
| Employee Compensation Payable |
3,919,769.49 |
| Taxes Payable |
49,145,009.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,899,241.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,034,436.11 |
| Other Current Liabilities |
106,077,930.17 |
| Sub-Total of Current Liabilities |
797,747,737.07 |
| Long-term Loans |
644,441,340.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
644,992,234.34 |
| Total Liabilities |
1,442,739,971.41 |
| Paid-In Capital(Or Share Stock) |
135,720,000.00 |
| Capital Surplus |
835,183,241.15 |
| Surplus Reserve |
70,230,677.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
582,821,285.80 |
| Minority Stockholder's Interest |
205,156,219.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,620,781,068.70 |
| Owner's Equity（Stockholder's Equity） |
1,825,937,288.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,268,677,259.58 |
